annual cash & cash equivalents:
$242.08M-$157.19M(-39.37%)Summary
- As of today (August 20, 2025), IONS annual cash & cash equivalents is $242.08 million, with the most recent change of -$157.19 million (-39.37%) on December 31, 2024.
- During the last 3 years, IONS annual cash & cash equivalents has fallen by -$627.11 million (-72.15%).
- IONS annual cash & cash equivalents is now -72.15% below its all-time high of $869.19 million, reached on December 31, 2021.
Performance
IONS Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$2.29B+$144.74M(+6.74%)Summary
- As of today (August 20, 2025), IONS quarterly cash & cash equivalents is $2.29 billion, with the most recent change of +$144.74 million (+6.74%) on June 30, 2025.
- Over the past year, IONS quarterly cash & cash equivalents has increased by +$214.28 million (+10.31%).
- IONS quarterly cash & cash equivalents is now -8.60% below its all-time high of $2.51 billion, reached on December 31, 2019.
Performance
IONS quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
IONS Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -39.4% | +10.3% |
| 3 y3 years | -72.2% | +13.4% |
| 5 y5 years | -64.6% | -2.5% |
IONS Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -72.2% | at low | -7.7% | +15.7% |
| 5 y | 5-year | -72.2% | at low | -7.7% | +25.8% |
| alltime | all time | -72.2% | >+9999.0% | -8.6% | >+9999.0% |
IONS Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $2.29B(+6.7%) |
| Mar 2025 | - | $2.15B(-6.7%) |
| Dec 2024 | $242.08M(-39.4%) | $2.30B(-7.3%) |
| Sep 2024 | - | $2.48B(+19.5%) |
| Jun 2024 | - | $2.08B(-5.8%) |
| Mar 2024 | - | $2.21B(-5.6%) |
| Dec 2023 | $399.27M(+44.4%) | $2.34B(+4.6%) |
| Sep 2023 | - | $2.24B(-6.3%) |
| Jun 2023 | - | $2.39B(+1.6%) |
| Mar 2023 | - | $2.35B(+17.5%) |
| Dec 2022 | $276.47M(-68.2%) | $2.00B(+0.8%) |
| Sep 2022 | - | $1.98B(-2.0%) |
| Jun 2022 | - | $2.02B(-2.0%) |
| Mar 2022 | - | $2.06B(-3.1%) |
| Dec 2021 | $869.19M(+118.6%) | $2.13B(+6.7%) |
| Sep 2021 | - | $2.00B(-3.2%) |
| Jun 2021 | - | $2.06B(+13.1%) |
| Mar 2021 | - | $1.82B(-4.0%) |
| Dec 2020 | $397.66M(-41.8%) | $1.90B(-18.7%) |
| Sep 2020 | - | $2.34B(-0.6%) |
| Jun 2020 | - | $2.35B(-1.6%) |
| Mar 2020 | - | $2.39B(-4.8%) |
| Dec 2019 | $683.29M(+145.1%) | $2.51B(+12.9%) |
| Sep 2019 | - | $2.22B(-1.8%) |
| Jun 2019 | - | $2.26B(+0.4%) |
| Mar 2019 | - | $2.25B(+8.1%) |
| Dec 2018 | $278.82M(+115.1%) | $2.09B(+6.5%) |
| Sep 2018 | - | $1.96B(-1.1%) |
| Jun 2018 | - | $1.98B(+91.3%) |
| Mar 2018 | - | $1.04B(+1.2%) |
| Dec 2017 | $129.63M(+53.1%) | $1.02B(+1.2%) |
| Sep 2017 | - | $1.01B(+18.1%) |
| Jun 2017 | - | $855.71M(-0.5%) |
| Mar 2017 | - | $860.28M(+28.9%) |
| Dec 2016 | $84.69M(-34.2%) | $667.64M(-4.2%) |
| Sep 2016 | - | $697.23M(+3.7%) |
| Jun 2016 | - | $672.31M(-7.1%) |
| Mar 2016 | - | $723.51M(-10.0%) |
| Dec 2015 | $128.80M(-9.9%) | $803.98M(-3.2%) |
| Sep 2015 | - | $830.79M(+1.9%) |
| Jun 2015 | - | $815.54M(+3.4%) |
| Mar 2015 | - | $788.50M(-2.7%) |
| Dec 2014 | $143.00M(-10.6%) | $810.71M(+26.6%) |
| Sep 2014 | - | $640.43M(-1.4%) |
| Jun 2014 | - | $649.37M(-6.5%) |
| Mar 2014 | - | $694.88M(-2.0%) |
| Dec 2013 | $159.97M(+28.5%) | $708.86M(-3.9%) |
| Sep 2013 | - | $737.44M(+12.7%) |
| Jun 2013 | - | $654.48M(+57.0%) |
| Mar 2013 | - | $416.77M(+2.1%) |
| Dec 2012 | $124.48M(+90.1%) | $408.07M(+18.8%) |
| Sep 2012 | - | $343.57M(+2.2%) |
| Jun 2012 | - | $336.03M(+0.6%) |
| Mar 2012 | - | $333.94M(+128.7%) |
| Dec 2011 | $65.48M(-6.5%) | - |
| Dec 2010 | $70.05M(-33.4%) | - |
| Dec 2009 | $105.25M(-51.7%) | - |
| Dec 2008 | $217.92M(+57.2%) | - |
| Dec 2007 | $138.61M(+21.0%) | - |
| Sep 2007 | - | $145.99M(-28.0%) |
| Jun 2007 | - | $202.73M(-29.0%) |
| Mar 2007 | - | $285.55M(+125.1%) |
| Dec 2006 | $114.51M | - |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2006 | - | $126.87M(+20.4%) |
| Jun 2006 | - | $105.36M(+6057.7%) |
| Mar 2006 | - | $1.71M(-53.1%) |
| Dec 2005 | $3.65M(-86.6%) | $3.65M(-93.1%) |
| Sep 2005 | - | $53.22M(+566.3%) |
| Jun 2005 | - | $7.99M(-33.5%) |
| Mar 2005 | - | $12.01M(-55.9%) |
| Dec 2004 | $27.25M(-17.7%) | $27.25M(+27.1%) |
| Sep 2004 | - | $21.45M(-29.4%) |
| Jun 2004 | - | $30.37M(-23.6%) |
| Mar 2004 | - | $39.76M(+20.1%) |
| Dec 2003 | $33.12M(-67.5%) | $33.12M(-40.6%) |
| Sep 2003 | - | $55.79M(-34.6%) |
| Jun 2003 | - | $85.32M(+39.7%) |
| Mar 2003 | - | $61.09M(-40.0%) |
| Dec 2002 | $101.86M(-19.8%) | $101.86M(+9.4%) |
| Sep 2002 | - | $93.08M(-15.4%) |
| Jun 2002 | - | $110.02M(+19.0%) |
| Mar 2002 | - | $92.45M(-27.2%) |
| Dec 2001 | $127.01M(+220.6%) | $127.01M(+931.7%) |
| Sep 2001 | - | $12.31M(-3.3%) |
| Jun 2001 | - | $12.74M(+58.1%) |
| Mar 2001 | - | $8.06M(-79.7%) |
| Dec 2000 | $39.62M(+12.2%) | $39.62M(-32.9%) |
| Sep 2000 | - | $59.03M(-4.9%) |
| Jun 2000 | - | $62.04M(-4.2%) |
| Mar 2000 | - | $64.73M(+83.4%) |
| Dec 1999 | $35.30M(+27.9%) | $35.30M(-7.8%) |
| Sep 1999 | - | $38.30M(+11.3%) |
| Jun 1999 | - | $34.40M(+69.5%) |
| Mar 1999 | - | $20.30M(-26.4%) |
| Dec 1998 | $27.60M(-27.6%) | $27.60M(-27.4%) |
| Sep 1998 | - | $38.00M(-2.3%) |
| Jun 1998 | - | $38.90M(+39.9%) |
| Mar 1998 | - | $27.80M(-27.0%) |
| Dec 1997 | $38.10M(+2.7%) | $38.10M(+31.8%) |
| Sep 1997 | - | $28.90M(-19.5%) |
| Jun 1997 | - | $35.90M(+37.0%) |
| Mar 1997 | - | $26.20M(-29.4%) |
| Dec 1996 | $37.10M(-20.2%) | $37.10M(+43.8%) |
| Sep 1996 | - | $25.80M(+1.2%) |
| Jun 1996 | - | $25.50M(+12.8%) |
| Mar 1996 | - | $22.60M(-51.4%) |
| Dec 1995 | $46.50M(+260.5%) | $46.50M(+87.5%) |
| Sep 1995 | - | $24.80M(+31.9%) |
| Jun 1995 | - | $18.80M(+13.3%) |
| Mar 1995 | - | $16.60M(+28.7%) |
| Dec 1994 | $12.90M(-61.7%) | $12.90M(-20.4%) |
| Sep 1994 | - | $16.20M(-12.0%) |
| Jun 1994 | - | $18.40M(-44.6%) |
| Mar 1994 | - | $33.20M(-1.5%) |
| Dec 1993 | $33.70M(+104.2%) | $33.70M(+88.3%) |
| Sep 1993 | - | $17.90M(-17.5%) |
| Jun 1993 | - | $21.70M(-19.6%) |
| Mar 1993 | - | $27.00M(+63.6%) |
| Dec 1992 | $16.50M(-22.2%) | $16.50M(+13.0%) |
| Sep 1992 | - | $14.60M(+10.6%) |
| Jun 1992 | - | $13.20M(-17.5%) |
| Mar 1992 | - | $16.00M(-24.5%) |
| Dec 1991 | $21.20M(+1077.8%) | $21.20M(+17.1%) |
| Sep 1991 | - | $18.10M(-46.1%) |
| Jun 1991 | - | $33.60M(+115.4%) |
| Mar 1991 | - | $15.60M(+766.7%) |
| Dec 1990 | $1.80M | $1.80M |
FAQ
- What is Ionis Pharmaceuticals, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Ionis Pharmaceuticals, Inc.?
- What is Ionis Pharmaceuticals, Inc. annual cash & cash equivalents year-on-year change?
- What is Ionis Pharmaceuticals, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Ionis Pharmaceuticals, Inc.?
- What is Ionis Pharmaceuticals, Inc. quarterly cash & cash equivalents year-on-year change?
What is Ionis Pharmaceuticals, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of IONS is $242.08M
What is the all time high annual cash & cash equivalents for Ionis Pharmaceuticals, Inc.?
Ionis Pharmaceuticals, Inc. all-time high annual cash & cash equivalents is $869.19M
What is Ionis Pharmaceuticals, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, IONS annual cash & cash equivalents has changed by -$157.19M (-39.37%)
What is Ionis Pharmaceuticals, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of IONS is $2.29B
What is the all time high quarterly cash & cash equivalents for Ionis Pharmaceuticals, Inc.?
Ionis Pharmaceuticals, Inc. all-time high quarterly cash & cash equivalents is $2.51B
What is Ionis Pharmaceuticals, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, IONS quarterly cash & cash equivalents has changed by +$214.28M (+10.31%)